Next Houston
Houston, Texas 77054
13 studies enrolling now · 14 studies all time
What they study most
Advanced Breast Cancer, Advanced Malignancies, Advanced Malignant Solid Tumor, Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic Solid Tumor, Advanced or Metastatic Solid Tumors, Breast Cancer, Cervical Cancer, Colorectal Cancer (Locally Advanced or Metastatic), Dedifferentiated Liposarcoma, EGFR Mutated Non-small Cell Lung Cancer Patients
Studies at this site
- A Study in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors — Recruiting now
- Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies — Recruiting now
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors — Recruiting now
- STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas — Recruiting now
- Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors — Recruiting now
- A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors — Recruiting now
- Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer — Recruiting now
- A First in Human Study of PLT012 in Participants With Solid Tumor Cancers — Recruiting now
- A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies — Recruiting now
- BTM-3566 in Advanced Solid Tumors — Recruiting now
- Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors — Recruiting now
- A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic — Starting soon
- A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors — Stopped early